Silexion Therapeutics Analyst Price Targets - Benzinga

SPY761.26−0.26%QQQ707.87−0.27%BTC/USD—DIA518.00−0.21%GLD381.40−0.16%TLT80.06+0.01%

Silexion Therapeutics Corp

SLXNNASDAQ

Trade with Public

Trade with Public

$0.1530

-0.036-19.05%

Last update: Oct 16, 7:52 PM

$0.1586

-0.0304-16.08%

Overview News Earnings Forecast EventsPrice TargetsFinancials Sentiment Ownership Compare Stock Report

Connect With Us

About Benzinga

Market Resources

Trading Tools & Education

Ring the Bell

© 2026 Benzinga | All Rights Reserved

Silexion Therapeutics Analyst Price Targets - Benzinga

Silexion Therapeutics Analyst Price Targets

Wall Street analyst price targets and consensus rating for Silexion Therapeutics (SLXN).

Price Target Range — 3 Quarters

Analyst Consensus — 2 Analysts

2Buy

Consensus RatingBuy# Analysts2Avg. Consensus PT$405Upside to Avg. PT+255259.4%

Rating Trend — Last 9 Months

Recent Analyst Actions

See all ratings →

Date	Firm	Analyst	Action	Rating Change	Price Target
Dec 15, 2025	Litchfield Hills	Theodore O'Neill	Initiate	Buy	$6
Mar 20, 2025	Maxim Group	Naz Rahman	PT Cut	Buy	$9→$5
Nov 1, 2024	Maxim Group	Naz Rahman	Initiate	Buy	$1

More with Benzinga EdgeGet Access

Analyst Ratings News

PRO
Litchfield Hills Initiates Coverage On Silexion Therapeutics with Buy Rating, Announces Price Target of $6

Litchfield Hills analyst Theodore O'Neill initiates coverage on Silexion Therapeutics (NASDAQ:SLXN) with a Buy rating and announces Price Target of $6.

Benzinga Newsdesk

PRO
Maxim Group Maintains Buy on Silexion Therapeutics, Lowers Price Target to $5

Maxim Group analyst Naz Rahman maintains Silexion Therapeutics (NASDAQ:SLXN) with a Buy and lowers the price target from $9 to $5.

Benzinga Newsdesk

PRO
Maxim Group Initiates Coverage On Silexion Therapeutics with Buy Rating, Announces Price Target of $1

Maxim Group analyst Naz Rahman initiates coverage on Silexion Therapeutics (NASDAQ:SLXN) with a Buy rating and announces Price Target of $1.

Benzinga Newsdesk